SCHEMBL16664936

SCHEMBL16664936

CCNc1cc(-c2ccc3[nH]c(=O)[nH]c3c2)ncn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25A P30304 1/20 0.45
▸ CDC25B P30305 1/20 0.45
▸ CDC25C P30307 1/20 0.45
▸ DUSP3 P51452 1/20 0.45
▸ PDE3B Q13370 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ AURKA O14965 1/20 0.42
▸ PDPK1 O15530 1/20 0.42
▸ TGFBR1 P36897 1/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ CYP1A2 P05177 8/20 0.41
▸ HSD17B10 Q99714 8/20 0.41
▸ ALDH1A1 P00352 8/20 0.41
▸ CYP3A4 P08684 7/20 0.41
▸ TP53 P04637 3/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22191011 0.84 CYP1A2 (0.59) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL22191291 0.82 CLK4 (0.46) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL15343345 0.76 CYP1A2 (0.53) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL15356477 0.76 KIT (0.50) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL16664932 0.72 EGFR (0.42) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL11786092 0.72 CYP1A2 (0.56) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL15343278 0.71 FAAH (0.50) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL16664928 0.70 CYP1A2 (0.50) AURKBCYP1A2HSD17B10ALDH1A1CYP3A4
SCHEMBL16664969 0.70 KDM4E (0.47) CYP1A2HSD17B10ALDH1A1CYP3A4TP53
SCHEMBL15343048 0.70 KDM4E (0.47) CYP1A2HSD17B10ALDH1A1CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015058031-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-04-23 — — WO disclosed
Send feedback